For the best experience of the website, please view this site in either Microsoft Edge, Google Chrome, Safari internet browsers rather than Internet Explorer.    
All sites now recruiting

IAA - Intranasal insulin and Abatacept trial

For the first time in Australia, researchers will carry out a type 1 diabetes trial to test two different immune therapies in children and young adults who have been recently diagnosed with type 1 diabetes.  The IAA trial is now recruiting participants in Melbourne, Perth, Adelaide, Brisbane and Sydney.

Our domains

What does ATIC do?

ATIC is working across six distinct interconnected Domains to ensure maximum impact and fulfil our bold vision.
News & Events

Beyond Insulin - September seminar

The next seminar in our Beyond Insulin series will take place Thursday the 21st of September from 1pm – 2pm. Associate Professor Stuart Mannering will present ‘Who killed my beta cells and why did they do it?’. Join us live for the seminar and Q&A.

Learn More
News & Events

News

T1D RELAY – New clinical trial now open

September 2023

ATIC and The Royal Melbourne Hospital are now seeking people aged 8-45 years with recently diagnosed type 1 diabetes (within three months) for a new clinical trial of two disease-modifying medications rituximab-pvvr and abatacept, called T1D RELAY.


Events

Who killed my beta cells and why did they do it?

September 2023

Seminar 10 of the Beyond Insulin Seminar Series features Associate Professor Stuart Mannering who will discuss one of the fundamental outstanding questions in the immunology of T1D – how and why does the immune system attack the insulin producing cells?


Events

Role of the gut microbiota in T1D

July 2023

Seminar 9 of the Beyond Insulin Seminar Series features Associate Professor Emma Hamilton-Williams. A/Prof Hamilton-Williams will discuss results from a clinical trial that aimed to restore a ‘healthy’ gut microbiota in adults with type 1 diabetes.


News

All trial sites for the Nasal Insulin and Abatacept (IAA Trial) are now open

June 2023

For the first time in Australia, researchers will carry out a type 1 diabetes trial to test two different immune therapies in children and young adults who have been recently diagnosed with type 1 diabetes.


Partnerships

We partner with global leaders in our field

Supported by
Coordinating Centre